Printer Friendly
The Free Library
19,607,059 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Corporate Profile for Merck & Co., Inc., dated May 26, 2000.


Business Editors

--(BUSINESS WIRE)

The following Corporate Profile is available for inclusion in your files. News releases for this client are distributed by Business Wire and also become part of the leading databases and online services, including all of the leading Internet-based services.


Published Date:     May 26, 2000

Company Name:       Merck & Co., Inc.

Address:            One Merck Drive
                    Whitehouse Station, NJ 08889

Main Telephone
 Number:            908/423-1000

Internet Home
 Page Address
  (URL)             www.merck.com

Chief Executive
 Officer:           Raymond V. Gilmartin

Chief Financial
 Officer:           Judy C. Lewent

Investor Relations
 Contact:           Laura Jordan
 Business number:   908/423-5185

Public Relations
 Contact:           Greg Reaves
 Business number:   908/423-6022

Industry:           Pharmaceutical

Trading Symbol/
 Exchange:          NYSE:MRK

Company Description:

      Merck & Co., Inc. is a global, research-driven pharmaceutical
company that discovers, develops, manufactures and markets a broad
range of human and animal health products, directly and through its
joint ventures, and provides pharmaceutical benefit services through
Merck-Medco Managed Care.

Total Employees: 62,300
Number of stockholders of record: 280,500


($ in millions except per share amounts)

Sales = $32,714.0
Research & development = $2,068.3
Net Income = $5,890.5
Earnings per common share assuming dilution = $2.45
Dividends paid per common share = $1.10


All Information Current for Year Ended December December: see month.  31, 1999
COPYRIGHT 2000 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2000, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:May 26, 2000
Words:207
Previous Article:Corporate Profile for ReQuest Multimedia, dated May 26, 2000.
Next Article:Corporate Profile for World Wide Motion Pictures, dated May 26, 2000.
Topics:



Related Articles
Multex.com News -- Multex.com ACE Consensus Estimates, Merck & Co. Inc.
Multex.com Stock Snapshot - Merck and Company Inc. MRK.
Corporate Profile for Merck & Co., Inc., dated Jan. 14, 2000.
Axonyx Inc. Names A.E. Cohen, Former Senior Vice President of Merck, to Its Board of Directors.
Judy C. Lewent Elected Executive Vice President of Merck & Co., Inc.; Ms. Lewent to Continue Her Role as CFO.
Rosetta Inpharmatics Launches Biosoftware Business Unit; Douglas E. Bassett, Jr., Ph.D., named Vice President & General Manager.
GlaxoSmithKline First to License the Rosetta Resolver Software Development Kit.
Rosetta Biosoftware Introduces Version 3.0 of the Rosetta Resolver System.
COR Therapeutics Licenses the Rosetta Resolver Gene Expression Data Analysis System.
Rosetta Resolver Gene Expression Data Analysis System Licensed by Aventis Pharmaceuticals, Inc.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles